Patents by Inventor Antoinette Naylor

Antoinette Naylor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Indazoles used to treat estrogen receptor beta mediated disorders
    Patent number: 7960563
    Abstract: The present invention relates to novel indazole derivatives having pharmacological activity, processes for their preparation, compositions containing them and uses of these compounds in the treatment of estrogen receptor beta mediated diseases.
    Type: Grant
    Filed: March 5, 2008
    Date of Patent: June 14, 2011
    Assignee: Glaxo Group Limited
    Inventors: Christopher Norbert Johnson, David G Jones, Xi Liang, David Timothy MacPherson, Aaron B Miller, Antoinette Naylor, Steven James Stanway, Andrew Kenneth Takle, Giancarlo Trani
  • IMIDAZOPYRIDINE DERIVATIVES AS ACID PUMP ANTAGONISTS
    Publication number: 20100311740
    Abstract: This invention relates to newly identified imidazopyridine compounds of formula (I), to the use of such compounds in treating GERD and the like.
    Type: Application
    Filed: June 28, 2006
    Publication date: December 9, 2010
    Inventors: Mark James Bamford, Richard Leonard Elliott, Gerard Martin Paul Giblin, Antoinette Naylor, Terence Aaron Chal, Andrew Kenneth Takle, Jason Witherington
  • Indazoles Used To Treat Estrogen Receptor Beta Mediated Disorders
    Publication number: 20100087502
    Abstract: The present invention relates to novel indazole derivatives having pharmacological activity, processes for their preparation, compositions containing them and uses of these compounds in the treatment of estrogen receptor beta mediated diseases.
    Type: Application
    Filed: March 5, 2008
    Publication date: April 8, 2010
    Applicant: GLAXO GROUP LIMITED
    Inventors: Christopher Norbert Johnson, David G. Jones, Xi Liang, David Timothy Macpherson, Aaron B. Miller, Antoinette Naylor, Steven James Stanway, Andrew Kenneth Takle, Giancarlo Trani
  • Pyridine derivatives as Raf kinase inhibitors
    Patent number: 7452906
    Abstract: Compounds and their use as pharmaceuticals particularly as Raf kinase inhibitors for the treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy.
    Type: Grant
    Filed: September 5, 2002
    Date of Patent: November 18, 2008
    Assignee: SmithKline Beecham P.L.C.
    Inventors: Mark James Bamford, David Kenneth Dean, Antoinette Naylor, Andrew Kenneth Takle, David Matthew Wilson
  • Derivatives of Imidazo [1,2-A] Pyridine Useful as Medicaments For Treating Gastrointestinal Diseases
    Publication number: 20080255358
    Abstract: Disclosed are imidazopyridine compounds having the formula:
    Type: Application
    Filed: March 22, 2006
    Publication date: October 16, 2008
    Inventors: Mark James Bamford, Emmanuel Hubert Demont, Richard Leonard Elliott, Gerard Martin Paul Giblin, Antoinette Naylor, Terence Aaron Panchal, Jason Witherington
  • Pyridylfurans and pyrroles as Raf kinase inhibitors
    Patent number: 7297694
    Abstract: Compounds and their use as pharmaceuticals particularly as Raf kinase inhibitors for the treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy.
    Type: Grant
    Filed: September 5, 2002
    Date of Patent: November 20, 2007
    Assignee: SmithKline Beechum P.L.C.
    Inventors: David Kenneth Dean, Antoinette Naylor, Andrew Kenneth Takle, David Matthew Wilson
  • Nitrogen-containing heterocyclic compounds and their use as Raf inhibitors
    Patent number: 7297693
    Abstract: Compounds and their use as pharmaceuticals particularly as Raf kinase inhibitors for the treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy.
    Type: Grant
    Filed: September 5, 2002
    Date of Patent: November 20, 2007
    Assignee: SmithKline Beecham P.L.C.
    Inventors: Mark James Bamford, David Kenneth Dean, Antoinette Naylor, Andrew Kenneth Takle, David Matthew Wilson
  • Pleuromutilin derivatives with antimicrobial activity
    Patent number: 7045524
    Abstract: Pleuromutilin compounds of the formula: are of use in anti-bacterial therapy.
    Type: Grant
    Filed: November 12, 2001
    Date of Patent: May 16, 2006
    Assignee: SmithKline Beecham p.l.c.
    Inventors: David Kenneth Dean, Antoinette Naylor, Andrew Kenneth Takle
  • Pleuromutilin derivatives with antimicrobial activity
    Publication number: 20050143393
    Abstract: Pleuromutilin compounds of the formula: are of use in anti-bacterial therapy.
    Type: Application
    Filed: November 12, 2001
    Publication date: June 30, 2005
    Inventors: David Dean, Antoinette Naylor, Andrew Takle
  • Pyridylfurans and pyrroles as raf kinase inhibitors
    Publication number: 20040254186
    Abstract: Compounds and their use as pharmaceuticals particularly as Raf kinase inhibitors for the treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy.
    Type: Application
    Filed: March 4, 2004
    Publication date: December 16, 2004
    Inventors: David Kenneth Dean, Antoinette Naylor, Andrew Kenneth Takle, David Matthew Wilson
  • Pyridine derivatives as raf kinase inhibitors
    Publication number: 20040235843
    Abstract: Compounds and their use as pharmaceuticals particularly as Raf kinase inhibitors for the treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy.
    Type: Application
    Filed: March 4, 2004
    Publication date: November 25, 2004
    Inventors: Mark James Bamford, David Kenneth Dean, Antoinette Naylor, Andrew Kenneth Takle, David Matthew Wilson
  • Nitrogen-containing heterocyclic compounds and their use as raf inhibitors
    Publication number: 20040209883
    Abstract: Compounds and their use as pharmaceuticals particularly as Raf kinase inhibitors for the treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy.
    Type: Application
    Filed: March 4, 2004
    Publication date: October 21, 2004
    Inventors: Mark James Bamford, David Kenneth Dean, Antoinette Naylor, Andrew Kenneth Takle, David Matthew Wilson
  • Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
    Patent number: 6121281
    Abstract: Compounds of formula (3), and pharmaceutically acceptable salts and derivatives thereof, in which R.sup.1 is vinyl or ethyl; and R.sup.2 is a group R.sup.3, R.sup.4 CH.sub.2 --, or R.sup.5 R.sup.6 C.dbd.CH--; wherein each of R.sup.3 and R.sup.4 is an azabicyclic ring system or R.sup.5 and R.sup.6 together with the carbon atom to which they are attached form an azabicyclic ring system, are useful in the prevention and treatment of microbial infections.
    Type: Grant
    Filed: January 29, 1999
    Date of Patent: September 19, 2000
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Andrew Kenneth Takle, Eric Hunt, Antoinette Naylor
  • 3-substituted carbacephems
    Patent number: 5716948
    Abstract: A compound of formula (I) or a salt thereof, wherein R.sup.1 is hydrogen, methoxy or formamido; R.sup.2 is an acyl group, in particular that of an antibacterially active cephalosporin; CO.sub.2 R.sup.3 is a carboxy group or a carboxylate anion, or R.sup.3 is a readily removable carboxy protecting group or a pharmaceutically acceptable salt-forming group or in vivo hydrolysable ester group; R.sup.4 represents hydrogen or up to four substituents, which may be present on any of the carbon atoms in the ring system shown, selected from alkyl, alkenyl, alkynyl, alkoxy, hydroxy, halogen, amino, alkylamino, acylamino, dialkylamino, CO.sub.2 R, CONR.sub.2, SO.sub.2 NR.sub.2 where R is hydrogen or alkyl, aryl and heterocyclyl, which may be the same or different and wherein any R.sup.4 alkyl substituent is optionally substituted by one or more substituents selected from the list from which R.sup.4 is selected; Y is O, S, SO or SO.sub.
    Type: Grant
    Filed: December 7, 1994
    Date of Patent: February 10, 1998
    Assignee: Pfizer Inc.
    Inventors: George Burton, Antoinette Naylor